Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA.
Intas licenses Helnius’s antibody for marketing in Europe and India – Pharmaceutical Technology
Serplulimab is a recombinant humanised anti-PD-1 monoclonal antibody (mAb) developed by Henlius. Image Credit: janews / Shutterstock. Intas Pharmaceuticals has signed an exclusive licensing agreement